Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study

Jun Te Hsu*, Puo Hsien Le, Chang Fu Kuo, Meng Jiun Chiou, Chia Jung Kuo, Tsung Hsing Chen, Chun Jung Lin, Jen Shi Chen, Huang Pin Yu, Chun Nan Yeh, Yi Yin Jan, Ta Sen Yeh

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science